Whitehawk Therapeutics In... (WHWK)
NASDAQ: WHWK
· Real-Time Price · USD
1.89
0.02 (1.07%)
At close: Jul 01, 2025, 3:59 PM
2.00
5.82%
After-hours: Jul 01, 2025, 06:43 PM EDT
Company Description
Whitehawk Therapeutics Inc operates as a clinical-stage biopharmaceutical company.
The Company develops precision therapies for genetically-defined cancers.
Whitehawk Therapeutics Inc
| Country | United States |
| IPO Date | Aug 1, 2017 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 40 |
| CEO | David J. Lennon |
Contact Details
Address: 17383 Sunset Blvd, Suite A250 Pacific Palisades, California United States | |
| Website | https://ir.whitehawktx.com |
Stock Details
| Ticker Symbol | WHWK |
| Exchange | NASDAQ |
| Fiscal Year | n/a |
| Reporting Currency | USD |
| CIK Code | n/a |
| CUSIP Number | 00032Q104 |
| ISIN Number | US00032Q1040 |
| Employer ID | - |
| SIC Code | n/a |
Key Executives
| Name | Position |
|---|---|
| Dr. David J. Lennon Ph.D. | President, Chief Executive Officer & Director |
| Scott M. Giacobello CPA | Chief Financial Officer, Treasurer, Investor Relations & Corporate Communications |
| Bryan Ball | Chief Technical Operations Officer |
| Dr. David Dornan Ph.D. | Chief Scientific Officer |
| Dr. Neil P. Desai Ph.D. | Founder & Director |
| Stephen M. Rodin J.D. | Senior Vice President of Legal & General Counsel |